| Line item | 2026-04-30 FY | 2025-04-30 FY | 2024-04-30 FY | 2023-04-30 FY | 2022-04-30 FY | 2021-04-30 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $19.00M | $13.01M | $7.26M | $9.40M | $14.95M | $12.39M |
| R&D | – | – | – | – | – | – |
| SG&A | $5.22M | $3.86M | $1.38M | $1.54M | $1.21M | $947.51K |
| Operating Income | -$19.00M | -$13.01M | -$7.26M | -$9.40M | -$14.95M | -$12.39M |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | – | – | – | – | – | – |
| Net Income | -$17.21M | -$20.56M | -$6.90M | -$7.61M | -$13.93M | -$12.39M |
| EPS (basic) | -1.1500 | -1.8000 | -0.7400 | -0.9000 | -1.9200 | -3.8000 |
| EPS (diluted) | -1.1500 | -1.8000 | -0.7400 | -0.9000 | -1.9200 | – |
| Shares (diluted) | $14.98M | $11.43M | $9.36M | $8.41M | $7.25M | – |